Prince Pharmaceutical Co., Ltd. (TPEX:6935)
Taiwan
· Delayed Price · Currency is TWD 29.00
0.00 (0.00%)
Apr 29, 2026, 1:45 PM CST
Prince Pharmaceutical Market Cap
Prince Pharmaceutical has a market cap or net worth of 1.06 billion as of April 28, 2026. Its market cap has increased by 26.64% in one year.
Market Cap
1.06B
Enterprise Value
1.33B
Revenue
1.06B
Ranking
n/a
PE Ratio
11.11
Stock Price
29.00
Market Cap Chart
Since March 29, 2023, Prince Pharmaceutical's market cap has decreased from 1.94B to 1.06B, a decrease of -45.38%. That is a compound annual growth rate of -17.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 1.06B | -6.75% |
| Dec 31, 2025 | 1.14B | 42.01% |
| Dec 31, 2024 | 801.65M | -36.72% |
| Dec 29, 2023 | 1.27B | -34.82% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anxo Pharmaceutical | 1.07B |
| Original BioMedicals | 1.01B |
| Mediera | 994.25M |
| Excelsior Biopharma | 1.18B |
| DV Biomed | 1.21B |
| Winston Medical Supply | 1.29B |
| GeneFerm Biotechnology | 1.62B |
| InnoPharmax | 1.66B |